TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA

Dintsios CM, Hagen A, Gerhardus A, Krauth C (2008)
In: Value in Health. VALUE IN HEALTH, 11(6). BLACKWELL PUBLISHING: A406.

Kurzbeitrag Konferenz / Poster | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Dintsios, C. M.; Hagen, A.; Gerhardus, AnsgarUniBi; Krauth, C.
Erscheinungsjahr
2008
Titel des Konferenzbandes
Value in Health
Band
11
Ausgabe
6
Seite(n)
A406
ISSN
1098-3015
Page URI
https://pub.uni-bielefeld.de/record/1636293

Zitieren

Dintsios CM, Hagen A, Gerhardus A, Krauth C. TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA. In: Value in Health. VALUE IN HEALTH. Vol 11. BLACKWELL PUBLISHING; 2008: A406.
Dintsios, C. M., Hagen, A., Gerhardus, A., & Krauth, C. (2008). TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA. Value in Health, VALUE IN HEALTH, 11, A406. BLACKWELL PUBLISHING. https://doi.org/10.1016/S1098-3015(10)66378-4
Dintsios, C. M., Hagen, A., Gerhardus, A., and Krauth, C. (2008). “TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA” in Value in Health VALUE IN HEALTH, vol. 11, (BLACKWELL PUBLISHING), A406.
Dintsios, C.M., et al., 2008. TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA. In Value in Health. VALUE IN HEALTH. no.11 BLACKWELL PUBLISHING, pp. A406.
C.M. Dintsios, et al., “TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA”, Value in Health, VALUE IN HEALTH, vol. 11, BLACKWELL PUBLISHING, 2008, pp.A406.
Dintsios, C.M., Hagen, A., Gerhardus, A., Krauth, C.: TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA. Value in Health. VALUE IN HEALTH. 11, p. A406. BLACKWELL PUBLISHING (2008).
Dintsios, C. M., Hagen, A., Gerhardus, Ansgar, and Krauth, C. “TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA”. Value in Health. BLACKWELL PUBLISHING, 2008.Vol. 11. VALUE IN HEALTH. A406.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Suchen in

Google Scholar